Novel 3-hydroxy-4-pyridinonato oxidovanadium(IV) complexes to investigate structure/activity relationships

Journal of Inorganic Biochemistry

Volumn 103, Issue 4, 2009, Pages 496-502

  Rangel, Maria ^a   Joao Amorim M ^a   Nunes, Ana ^a   Leite, Andreia ^a   Pereira, Eulália ^a   Castro, Baltazar de ^a   Sousa, Carla ^b   Yoshikawa, Yutaka ^c   Sakurai, Hiromu ^d  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^d SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

3 Hydroxy 4 pyridinones; Inhibition of FFA release; Insulin enhancing compounds; Oxovanadium(IV) complexes

Indexed keywords

3 HYDROXY 4 PYRIDINONATO OXIDOVANADIUM; FATTY ACID; NITROGEN; UNCLASSIFIED DRUG; VANADIUM; VANADIUM DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG SYNTHESIS; HYDROPHILICITY; IC 50; INSULIN LIKE ACTIVITY; LIPOPHILICITY; MALE; NONHUMAN; OXIDATION; RAT; REDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; HYPOGLYCEMIC AGENTS; MALE; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; VANADIUM;

RATTUS;

EID: 62349102322     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2008.12.019     Document Type: Article

References (25)

1. Lyonnet B.M., and Martin E.M. La Presse Med. 7 (1899) 191-192
2. Sakurai H. Expert Opin. Drug Discov. 2 (2007) 873-887
3. Thompson K.H., and Orvig C. J. Inorg. Biochem. 100 (2006) 1925-1935
4. Crans D.C., Smee J.J., Gaidamauskas E., and Yang L. Chem. Rev. 104 (2004) 849-902
5. Thompson K.H., and Orvig C. Met. Ions Biol. Syst. 41 (2004) 221-252
6. Rehder D. Inorg. Chem. Commun. 6 (2003) 604-617
7. Sakurai H., Tamura A., Fugono J., Yasui H., and Kiss T. Coord. Chem. Rev. 245 (2003) 31-37
8. Thompson K.H., McNeill J.H., and Orvig C. Chem. Rev. 99 (1999) 2561-2571
9. K.H. Thompson, P.F. Salas, J.H. McNeil, J.B. Lichter, M.S. Caife, C. Orvig, Book of Abstracts of the 6th International Vanadium Symposium, Oral Communication O24, Lisbon, 2008.
10. Burgess J., and Rangel M. Adv. Inorg. Chem. 60 (2008) 167-243
11. Rangel M., Leite A., Amorim M.J., Garriba E., Micera G., and Lodyga-Chruscinska E. Inorg. Chem. 45 (2006) 8086-8097
12. Castro M.M.C.A., Avecilla F., Geraldes C.F.G.C., and Rangel M. Inorg. Chim. Acta 356 (2003) 142-154
13. Rehder D., Costa Pessoa J., Geraldes C.F.G.C., Castro M.M.C.A., Kabanos T., Kiss T., Meier B., Micera G., Pettersson L., Rangel M., Salifoglou A., Turel I., and Wang D. J. Biol. Inorg. Chem. 7 (2002) 384-396
14. Rangel M., Tamura A., Fukushima C., and Sakurai H. J. Biol. Inorg. Chem. 6 (2001) 128-132
15. Rangel M. Transition Met. Chem. 26 (2001) 219-223
16. Castro M.M.C.A., Geraldes C.F.G.C., Gameiro P., Pereira E., Castro B., and Rangel M. J. Inorg. Biochem. 80 (2000) 177-179
17. Burgess J., de Castro B., Oliveira C., Rangel M., and Schlindwein W. Polyhedron 16 (1997) 789-794
18. Zhang Z., Rettig S.J., and Orvig C. Inorg. Chem. 30 (1991) 509-515
19. Finnegan M.M., Rettig S.J., and Orvig C. J. Am. Chem. Soc. 108 (1986) 5033-5035
20. Schlindwein W., Waltham E., Burgess J., Binsted N., Nunes A., Leite A., and Rangel M. Dalton Trans. (2006) 1313-1321
21. Bard A.J., and Faulkner L.R. Electrochemical Methods (1980), Wiley, New York
22. Watanabe H., Nakai M., Komazawa K., and Sakurai H. J. Med. Chem. 37 (1994) 876-877
23. Sakurai H., and Tsuji A. In: Nriagu J.O. (Ed). Vanadium in the Environment, Part 2, Health Effects (1998), John Wiley & Sons, New York 297-315
24. H. Sakurai, K. Fujii, S. Fujimoto, Y. Fujisawa, K. Takechi, H. Yasui, in: A.S. Tracey, D.C Crans (Eds.), Vanadium Compounds: Chemistry, Biochemistry, And Therapeutic Applications, ACS Symposium Series 711, American Chemical Society. 1998, pp. 344-352.
25. Nakai M., Watanabe W., Fujiwara C., Kakegawa H., Satoh T., Takada J., Matsushita R., and Sakurai H. Biol. Pharm. Bull. 18 (1995) 719-725